GENABIO

Our Mission is to enhance global health awareness and accessibility, by delivering quality, FDA-approved self-test kits, by driving innovation, and by expanding our reach to ensure individuals can monitor their health with precision and convenience... In 2023, Genabio marked a pivotal moment by initiating our listing and financing efforts in Hong Kong. Simultaneously, we are focused on enhancing our brand identity and emphasizing clinical research within the United States. This commitment to research and development aligns with our expansion plans, which encompass increasing our production capacity in both the United States and China... Our overarching vision is to be the world's foremost provider of self-testing solutions, offering precise, user-friendly, and cost-effective health diagnostics for individuals worldwide.

Also known as: Genabio Diagnostics, Genabio Diagnostics Inc.

Primary location: Bedford United States